TANDEM DIABETES CARE INC

Key metrics

Financial performance

Over the last 9 fiscal years TANDEM DIABETES CARE INC's revenue grew from $84.25M to $1.01B, a compound annual growth rate of 31.9%. Net profit margin expanded from -99.0% to -20.2% over the same period - every figure below comes from the company's audited annual filings.

Dig into the full income statement, balance sheet, and cash flow statement with annual and quarterly views.

Key statistics

Latest filings

Browse the full filing history (1,234 filings)

Recent press releases

• Tandem Diabetes Care Announces First Quarter 2026 Financial Results2026-05-07

  Tandem Diabetes Care Announces First Quarter 2026 Financial Results | Tandem Diabetes Care

• Tandem Diabetes Care Announces Upcoming Conference Presentations2026-04-29

  Tandem Diabetes Care Announces Upcoming Conference Presentations | Tandem Diabetes Care

• Tandem Diabetes Care’s Control-IQ+ Automated Insulin Delivery Technology Now FDA Cleared for Pregnancy in Type 1 Diabetes2026-04-27

  Tandem Diabetes Care’s Control-IQ+ Automated Insulin Delivery Technology Now FDA Cleared for Pregnancy in Type 1 Diabetes | Tandem Diabetes Care

• Tandem Diabetes Care to Announce First Quarter 2026 Financial Results on May 7, 20262026-04-02

  A live webcast of the call will be available on Tandem Diabetes Care’s Investor Center website located at http://investor.tandemdiabetes.com in the “Events & Presentations” section. To access the call by phone, please use this link ( https://register-conf.media-server.com/register/BI870b8c6fdaae4b6d982fb59187bc9470 ) and you will be provided with dial-in details, including a personal pin.

• Tandem Mobi Now Compatible with Android Smartphones2026-03-04

  Tandem Mobi Now Compatible with Android Smartphones | Tandem Diabetes Care

Similar companies

The largest companies sharing TANDEM DIABETES CARE INC's SEC industry classification (surgical & medical instruments & apparatus).